ArticleProceedings of the National Academy of Sciences of the United States of America2014

Evolution of ibrutinib resistance in chronic lymphocytic leukemia (CLL).

Natalia L Komarova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.